IASLC Foundation

2018 IASLC Foundation Winners

IASLC Foundation Fellowships and Young Investigator Winners

 

2018_IASLC_Fellowship_Winners

IASLC Foundation Fellowship Winners:


Dr. Dimou Anastasios

Non-genetic determinants of EGFR TKI resistance in EGFR mutant lung cancer
University of Colorado

Dr. Sanghyuk Song

Development of advanced stereotactic ablative radiotherapy for early-stage lung cancer; respiratory gating with inflated lung using a high-flow nasal cannula system
Kangwon National University Hospital

Dr. Laura Mezquita

European observational study of the indoor radon in non-small cell lung cancer (NSCLC) patients harboring driver molecular alterations
Institut Gustave Roussy

 

Young Investigator Award Winners:

Young_Investigator_Award_Winners

Dr. Benjamin Lok

Development of Epigenetic Therapeutics for Small Cell Lung Cancer
Princess Margaret Cancer Centre

Dr. John Charles Rotondo

A3 and P2X7 receptors as new targets for a potential innovative therapy of the malignant pleural mesothelioma
University of Ferrara

Dr. Aaron Tan

Minimally-invasive detection of early recurrence with circulating tumour DNA (ctDNA) in patients with resected early stage EGFR mutant non-small lung cancer (NSCLC)
   National Cancer Centre Singapore

 

 

IASLC Foundation Partnership Grant Winners 

 

Free ME From Lung Cancer (FMFLC) and IASLC Foundation Joint Fellowship Award for the Early Detection of Lung Cancer:


Dr. Eva Koziolek

A novel biomarker for diagnosis and treatment of lung pre-malignancy
University of California Los Angeles

 
LCFA and IASLC Foundation Lori Monroe Scholarship in Translational Lung Cancer Research:

Lori_Monroe_Winners

 
Dr. Alice Berger

Genomic Characterization of Lung Cancer in Never-Smokers
University of Washington

Dr. Christine Lovly

Understanding dynamic somatic genome changes and hereditary predisposition in patients with small cell lung cancer
Vanderbilt University School of Medicine

 

LCFA-BMS/IASLC Foundation Young Investigator Award:

  
Dr. Zoltan Lohinai

Interaction of immunotherapy with the mycobiome in lung adenocarcinoma
National Koranyi Institute of Pulmonology

Dr. Kathryn Beckermann

Single cell analysis to understand the biological response to novel immunotherapy combination in lung cancer
Vanderbilt University School of Medicine

 

See Past Foundation Winners